Details for New Drug Application (NDA): 213053
✉ Email this page to a colleague
The generic ingredient in MUPIROCIN is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 213053
Tradename: | MUPIROCIN |
Applicant: | Alembic |
Ingredient: | mupirocin calcium |
Patents: | 0 |
Pharmacology for NDA: 213053
Mechanism of Action | RNA Synthetase Inhibitors |
Suppliers and Packaging for NDA: 213053
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 213053 | ANDA | Alembic Pharmaceuticals Inc. | 62332-624 | 62332-624-15 | 1 TUBE in 1 CARTON (62332-624-15) / 15 g in 1 TUBE |
MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 213053 | ANDA | Alembic Pharmaceuticals Inc. | 62332-624 | 62332-624-30 | 1 TUBE in 1 CARTON (62332-624-30) / 30 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | EQ 2% BASE | ||||
Approval Date: | Nov 16, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription